What is Artiva Biotherapeutics, Inc.'s operating cash flow?

Artiva Biotherapeutics, Inc. (ARTV) reported operating cash flow of -$20.95M in Q1 2026.

How has Artiva Biotherapeutics, Inc.'s operating cash flow changed year-over-year?

Artiva Biotherapeutics, Inc.'s operating cash flow decreased by 5.6% year-over-year, from -$19.84M to -$20.95M.

What does operating cash flow mean?

Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Artiva Biotherapeutics, Inc. ARTV Operating Cash Flow

Operating Cash Flow at other companies

Bristol-Myers SquibbBMY

$1.1B-43.5%

Gilead SciencesGILD

$2.54B+44.8%

Kyverna Therapeutics, Inc.KYTX

-$41.6M+7.4%

Allogene TherapeuticsALLO

-$12.91M+75.6%

Immix Biopharma, Inc.IMMX

-$9.83M-483%

ImmunityBio, Inc.IBRX

-$75.36M+12.3%

Other financials

Income statement

See full

Revenue-—

Operating income-$24.4M-10.2%

Net income-$23.5M-15.8%

EPS (diluted)-$0.95-14.5%

Balance sheet

See full

Cash & equivalents$21.4M-30.6%

Total debt$10.3M-26.7%

Total equity$87.8M-48.0%

Total assets$106.0M-44.6%

Cash flow

See full

CapEx$242.0K-52.6%

Free cash flow-$21.2M-4.1%

Valuation

See full

Market cap$429.03M+1,015%

Enterprise value$417.88M+1,832%

Profitability

See full

Operating margin-83.9%—

Net margin-79.3%—

Returns & leverage

See full

Return on equity-67.9%—

Debt / equity0.1×0.0×

Current ratio8.2×-5.8×

Where this comes from

Reported directly by Artiva Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artiva Biotherapeutics, Inc.'s operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Artiva Biotherapeutics, Inc.'s operating cash flow?: Artiva Biotherapeutics, Inc. (ARTV) reported operating cash flow of -$20.95M in Q1 2026.
How has Artiva Biotherapeutics, Inc.'s operating cash flow changed year-over-year?: Artiva Biotherapeutics, Inc.'s operating cash flow decreased by 5.6% year-over-year, from -$19.84M to -$20.95M.
What does operating cash flow mean?: Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.